Table 5 Levels of inflammatory cytokines at admission in different subgroups of patients who developed ARDS (n = 42)*
Outcome | Subgroups | IL-6 | P value | IL-8 | P value | IL-10 | P value | TNF-α | P value |
|---|---|---|---|---|---|---|---|---|---|
Septic shock | Yes (n = 33) | 54.88 (26.64–161.65) | 0.29 | 21.90 (13.05–60.70) | 0.417 | 10.50 (5.30–20.05) | 0.127 | 10.3 (7.15–19.70) | 0.391 |
|  | No (n = 9) | 31.76 (19.30–72.91) |  | 29.9 (20.20–72.10) |  | 6.10 (4.25–13.35) |  | 9.3 (7.6–10.7) |  |
DIC | Yes (n = 21) | 96.99 (37.62–214.90) |  < 0.001 | 47.00 (19.3–103.25) | 0.016 | 14.40 (5.85–25.4) | 0.006 | 11.0 (7.8–26.4) | 0.131 |
|  | No (n = 21) | 29.32 (11.23–47.98) |  | 17.50 (11.95–30.45) |  | 6.20 (5.0–9.85) |  | 9.30 (7.15–12.35) |  |
AKI | Yes (n = 21) | 59.83 (31.02–200.90) | 0.013 | 30.50 (15.55–103.25) | 0.199 | 10.70 (5.40–20.05) | 0.087 | 11.30 (8.4–26.4) | 0.047 |
|  | No (n = 21) | 35.50 (18.11–106.09) |  | 22.90 (12.75–55.20) |  | 6.4 (5.0–13.20) |  | 9.30 (6.85–10.9) |  |
Cardiac injury | Yes (n = 33) | 59.83 (26.64–161.65) | 0.112 | 30.30 (14.50–75.25) | 0.567 | 10.7 (5.3–20.05) | 0.112 | 10.30 (7.30–19.70) | 0.171 |
|  | No (n = 9) | 29.54 (19.30–47.98) |  | 22.90 (15.45–48.55) |  | 6.1 (4.23–11.0) |  | 9.30 (6.9–9.77) |  |
Hepatic injuryy | Yes (n = 13) | 64.78 (34.74–186.15) | 0.268 | 30.30 (16.80–89.60) | 0.419 | 10.08 (5.3–25.4) | 0.332 | 11.30 (7.45–41.55) | 0.257 |
|  | No (n = 29) | 43.38 (20.98–99.99) |  | 21.90 (13.70–68.45) |  | 7.9 (5.12–15.0) |  | 9.5 (7.5–13.05) |  |
28-day survival | No (n = 32) | 60.46 (30.36–185.03) | 0.018 | 30.01 (14.25–71.93) | 0.432 | 10.8 (5.4–24.08) | 0.014 | 10.30 (7.48–19.68) | 0.247 |
|  | Yes (n = 10) | 28.81 (10.12–47.55) |  | 23.95 (16.48–42.50) |  | 5.5 (4.19–8.18) |  | 8.6 (6.45–10.50) |  |